Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
XTENT INC (XTNT) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/16/2010 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/27/2009 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
08/27/2009 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/27/2009 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
08/13/2009 8-K Quarterly results
08/05/2009 8-K Form 8-K - Current report
07/31/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/24/2009 10-Q Quarterly Report for the period ended June 30, 2009
07/07/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
07/07/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "XTENT, Inc. Announces that it has Postponed the Special Meeting of its Stockholders"
06/08/2009 DEF 14A Form DEF 14A - Other definitive proxy statements
06/08/2009 SC 13G/A Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
06/04/2009 8-K Other Events, Financial Statements and Exhibits
Docs: "XTENT Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX® Drug Eluting Stent System from United States Food and Drug Administration"
05/15/2009 8-K Form 8-K -- Current report
05/15/2009 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
05/15/2009 10-Q Quarterly Report for the period ended March 31, 2009
04/30/2009 10-K/A Annual Report for the period ended December 31, 2008 [amend]
04/06/2009 8-K Form 8-K -- Current report
03/24/2009 10-K Annual Report for the period ended December 31, 2008
02/20/2009 8-K Quarterly results
Docs: "XTENT Announces Fourth Quarter 2008 Financial Results and Business Progress"
02/17/2009 SC 13G/A Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
02/11/2009 8-K Form 8-K -- Current report
02/03/2009 SC 13G STATE OF WISCONSIN INVESTMENT BOARD reports a 5.5% stake in XTENT, Inc.
01/27/2009 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
11/12/2008 10-Q Quarterly Report for the period ended September 30, 2008
11/04/2008 8-K Quarterly results
Docs: "XTENT Announces Third Quarter 2008 Financial Results"
10/01/2008 4 Form 4 - Statement of changes in beneficial ownership of securities
09/02/2008 4 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) has filed a Form 4 on XTENT INC
Txns: Sold 50 shares @ $1.97, valued at $98.5
Sold 4,400 shares @ $2, valued at $8.8k
Sold 350 shares @ $2.01, valued at $703.5
Sold 100 shares @ $2.05, valued at $205
Sold 100 shares @ $2.07, valued at $207
08/15/2008 4 Andreas Bernard H (VP-Innovation and Concept Dev) has filed a Form 4 on XTENT INC
Txns: Granted 15,000 options to buy @ $2.1, valued at $31.5k
08/15/2008 4 Campbell Randolph E (Chief Technical Officer) has filed a Form 4 on XTENT INC
Txns: Granted 10,418 options to buy @ $2.1, valued at $21.9k
Granted 14,582 options to buy @ $2.1, valued at $30.6k
08/15/2008 4 Casciaro Gregory D (President and CEO) has filed a Form 4 on XTENT INC
08/15/2008 4 Hodkinson Anne-Marie (VP Human Resources) has filed a Form 4 on XTENT INC
Txns: Granted 7,005 options to buy @ $2.1, valued at $14.7k
Granted 34,995 options to buy @ $2.1, valued at $73.5k
08/15/2008 4 Kahlenberg Timothy D (CFO) has filed a Form 4 on XTENT INC
Txns: Granted 6,738 options to buy @ $4.5, valued at $30.3k
Granted 9,427 options to buy @ $4.5, valued at $42.4k
08/15/2008 4 Marco Philippe H (VP-QA, Clinical & Reg. Affairs) has filed a Form 4 on XTENT INC
Txns: Granted 10,418 options to buy @ $2.1, valued at $21.9k
Granted 14,582 options to buy @ $2.1, valued at $30.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy